29648-66-6

Basic information

• Product Name: 4-Methylenecyclohexanone
• Synonyms: 4-Methylenecyclohexanone;4-methylenecyclohexan-1-one
• CAS NO: 29648-66-6
• Molecular Formula: C₇H₁₀O
• Molecular Weight: 110.1537
• Mol File: 29648-66-6.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Methylenecyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methylenecyclohexanone(29648-66-6)
• EPA Substance Registry System: 4-Methylenecyclohexanone(29648-66-6)

Safety Data

• Hazardous Substances Data: 29648-66-6(Hazardous Substances Data)

Usage

General Description

4-Methylenecyclohexanone, also known as piperonyl ketone, is a chemical compound with the molecular formula C8H12O. It is a colorless liquid with a strong, floral odor that is commonly used as a flavoring agent in the food industry. It is also used as a precursor in the synthesis of fragrances and pharmaceuticals. Additionally, 4-Methylenecyclohexanone is a key intermediate in the production of piperonylmethyl ketone, which is used in the manufacture of amphetamine and methamphetamine. The compound is flammable and should be handled with care, as it poses a risk of fire and explosion. Overall, 4-Methylenecyclohexanone has important applications in the food, fragrance, and pharmaceutical industries, but its handling requires strict safety measures.

Upstream product

• 71435-94-4 <(4-Methoxy-1.4-cyclohexadien-1-yl)methyl>trimethylsilan 
• 13482-22-9 4-hydroxycyclohexanone 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 51656-90-7 8-methylene-1,4-dioxaspiro[4.5]decane 
• 19740-31-9 spiro{2.4}heptan-5-one 
• 22428-85-9 4-Methylencyclohexanol 

Downstream Products

• 861859-51-0 1-(3-tert-butyl-phenyl)-4-methylene-cyclohexanol 
• 1477524-75-6 1-(4-bromophenyl)-4-methylenecyclohexanol 
• 1398924-07-6 d9-1-[4-fluoro-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxymethyl]-7-oxa-bicyclo[2.2.1]heptane 
• 1398924-03-2 1-[4-fluoro-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxymethyl]-7-oxa-bicyclo[2.2.1]heptane 
• 1398924-05-4 1-(3-bromo-4-fluoro-phenoxymethyl)-7-oxa-bicyclo[2.2.1]heptane 
• 1398923-73-3 1-[2-fluoro-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxymethyl]-7-oxa-bicyclo[2.2.1]heptane 
• 1398923-75-5 1-(3-bromo-2-fluoro-phenoxymethyl)-7-oxa-bicyclo[2.2.1]heptane 
• 1272670-06-0 5-(3-(7-oxabtcyclo[2.2.1]heptan-1-ylmethoxy)phenyl)-7-((1S,4S)-4-(aminomethyl)cyclohexyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 
• 1272666-89-3 2-(3-((7-oxabicyclo[2.2.1]heptan-1-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1272667-52-3 5-(3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl)-7-((1s,4s)-4-(azidomethyl)cyclohexyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 
• 1272667-53-4 ((1S,4S)-4-(5-(3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl)-4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)methyl methanesulfonate 
• 1272667-38-5 (1S,4S)-4-(5-(3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl)-4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanecarbaldehyde 
• 1272667-39-6 ((1S,4S)-4-(5-(3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl)-4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)methanol 
• 82353-67-1 4-Methylene-1-pent-4-enyl-cyclohexene 

Relevant articles and documents

CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS

The invention relates to compounds of formula (I): useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.

HYDROXY SUBSTITUTED ISOQUINOLINONE DERIVATIVES

The invention relates to compounds of formula (I): as defined in the application. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of MDM2 and/or MDM4, or variants thereof.

Design and synthesis of cell potent BACE-1 inhibitors: Structure-activity relationship of P1′ substituents

Using structure-guided design, hydroxyethylamine BACE-1 inhibitors were optimized to nanomolar Aβ cellular inhibition with selectivity against cathepsin-D. X-ray crystallography illuminated the S1′ residues critical to this effort, which culminated in compounds 56 and 57 that exhibited potency and selectivity but poor permeability and high P-gp efflux.